Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
82.37%
Grew
—
—
Grew
—
1 Year
Score—
Net Growth82.37%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendGrew
Revenue Consistency—
5 Years
5.0
63.38%
40%
—
9x
40%
—
5 Years
Score5.0
Net Growth63.38%
Net Trend40%
Net Income Consistency—
Rev Growth9x
Rev Trend40%
Revenue Consistency—
vTv Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 6M to $ 0.00 and net income went from -$ 8M to -$ 26M. Revenue increased in 2 of those 5 years; net income in 2.
Across vTv Therapeutics Inc's full reported history, from 2015 to 2025, revenue declined from $ 519K to $ 0.00 and net income went from -$ 27M to -$ 26M. Revenue increased in 45% of the years measured; net income in 55%.
vTv Therapeutics Inc currently holds a 5-year HDB Score of 5.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 31.78 | — |
1 Year2025-08-12 | $ 14.49 | 119.32% |
5 Years2021-08-12 | $ 75.20 | -57.74% |
10 Years2016-08-12 | $ 239.60 | -86.74% |
All Time2015-07-30 | $ 435.60 | -92.70% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2015-07-30 |
|---|---|---|---|---|---|
| Price | $ 31.78 | $ 14.49 | $ 75.20 | $ 239.60 | $ 435.60 |
| Return | — | 119.32% | -57.74% | -86.74% | -92.70% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 36M | -$ 4M | $ 86M |
| 2025 | $ 0.00 | -$ 26M | $ 88M |
| 2024 | $ 1M | -$ 18M | $ 36M |
| 2023 | $ 9K | -$ 20M | $ 9M |
| 2022 | $ 2M | -$ 19M | $ 12M |
| 2021 | $ 4M | -$ 12M | $ 13M |
| 2020 | $ 6M | -$ 8M | $ 5M |
| 2019 | $ 2M | -$ 21M | $ 1M |
| 2018 | $ 12M | -$ 7M | $ 1M |
| 2017 | $ 291K | -$ 16M | $ 11M |
| 2016 | $ 634K | -$ 16M | $ 51M |
| IPO2015 | $ 519K | -$ 27M | $ 88M |
Explore beyond VTVT
You're looking at vTv Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
